ACADIA Pharmaceuticals Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving ACADIA Pharmaceuticals Inc. now
Current reporting with the operating signal separated from the noise.
Acadia Pharmaceuticals Inc. (DR6.SG) Q1 FY2026 earnings call transcript
Investors are testing whether ACADIA Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.ACADIA Pharmaceuticals Inc.
The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ACADIA Pharmaceuticals Inc. (ACAD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial
The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ACAD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
ACADIA Pharmaceuticals Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →